Viewing Study NCT05385250


Ignite Creation Date: 2025-12-24 @ 5:16 PM
Ignite Modification Date: 2026-01-31 @ 2:38 AM
Study NCT ID: NCT05385250
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-08-15
First Post: 2022-02-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-II
Sponsor: Karen-Lise Garm Spindler
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module